Clinical Trials in Atlanta

Showing 3421-3440 of 19,805 trials

Abatacept as GVHD Prophylaxis Phase 2

NCT01743131

This is a phase II multi-center, randomized, double blind, placebo-controlled trial. The investigators are doing this study to see if a new drug, abatacept, can be used together with a calcineurin inhibitor (cyclosporine or tacrolimus) and methotrexate to provide better protection against Acute Graft versus Host Disease (aGvHD) without causing more infections.

Graft vs Host DiseaseMalignancy

Boston Children's Hospital186 participantsStarted Feb 2013

Los Angeles, California, United States • Oakland, California, United States • Aurora, Colorado, United States +11 more locations

COMPLETEDNA< 1 mile

Role of Early Motor Experience in Infants With Down Syndrome

NCT05144373

Infants with Down syndrome show significant delays and weaknesses in motor, cognitive, and language development compared to typically developing infants. This project aims to examine the developmental cascade effects of specific gross and fine motor experience on motor, cognitive and language development in infants with Down syndrome. We propose that both gross and fine motor experience will facilitate cognitive and language development in infants with Down syndrome, and particularly, fine motor experience will help advance gesture and early words production.

Down Syndrome

Georgia State University51 participantsStarted Jan 2022

Atlanta, Georgia, United States

Abatacept as GVHD Prophylaxis Phase 2

Role of Early Motor Experience in Infants With Down Syndrome

Find Trials by Condition in Atlanta

A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease

Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension

Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

A Phase 1 Trial of Intranasal Mumps Virus Vaccines in Healthy Adults

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP

Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Treatment of Moderate to Severe Refractory Crohn's Disease

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma

CapTemY90 for Grade 2/3 NET Liver Metastases

Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity

Evaluation of A Clinical Diagnostic Test for CRDS